An Overview
Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs 10,700 crores (FY2024) is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), women healthcare (WHC), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent Pharma has crossed many geographical boundaries with presence in more than 50 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany.
0
Manufacturing Plants
0+
Scientists0+
Product Registrations0+
CountriesOur Reach
Marketing Presence in 50+ Countries
India
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
International
With significant presence in more than 50 countries, Torrent is all poised to spread wings across globe with strong technical capabilities and international accreditations. To enable strategic differentiation, Torrent Pharma’s international business is segregated into US, UK, Germany, Europe, Brazil and Rest of the World.
Consumer Healthcare Brands
We care about your overall health
Therapeutic Areas
Therapeutic areas encompass specialized medical fields dedicated to treating specific diseases or conditions for improved patient health outcomes.
Gastro Intestinal
Neuro-Psychiatric
Gynecology
Nephrology
Oncology
Anti-Microbial
Cardiovascular
Many More
Environment & Sustainability
As much as Torrent is helping the people of our society, we also are very conscious of our environment and our daily impacts on sustainability.
Torrent Pharma is committed to sustainability and responsible practices. We have set ambitious targets for reducing our greenhouse gas emissions and are constantly exploring new ways to reduce the impact of our operations on the environment. Towards this, we have been continuously diversifying our energy mix with cleaner fuels and renewable sources. We will also be identifying interventions to reduce our dependency on grid electricity. As a part of the ESG roadmap, we have invested in Hybrid Solar-Wind project to meet our captive power requirement and to reduce our carbon footprints significantly
